iX Biopharma (SGX:42C) Days Payable : 162.98 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is iX Biopharma Days Payable?

iX Biopharma's average Accounts Payable for the six months ended in Dec. 2024 was S$2.58 Mil. iX Biopharma's Cost of Goods Sold for the six months ended in Dec. 2024 was S$2.88 Mil. Hence, iX Biopharma's Days Payable for the six months ended in Dec. 2024 was 162.98.

The historical rank and industry rank for iX Biopharma's Days Payable or its related term are showing as below:

SGX:42C' s Days Payable Range Over the Past 10 Years
Min: 31.44 Med: 136.25 Max: 1666.19
Current: 176.39

During the past 11 years, iX Biopharma's highest Days Payable was 1666.19. The lowest was 31.44. And the median was 136.25.

SGX:42C's Days Payable is ranked better than
80.56% of 921 companies
in the Drug Manufacturers industry
Industry Median: 87.93 vs SGX:42C: 176.39

iX Biopharma's Days Payable increased from Dec. 2023 (154.70) to Dec. 2024 (162.98). It may suggest that iX Biopharma delayed paying its suppliers.

iX Biopharma Days Payable Historical Data

The historical data trend for iX Biopharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iX Biopharma Days Payable Chart

iX Biopharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Days Payable

Get a 7-Day Free Trial

152.55

119.95

67.26

31.44

61.50

iX Biopharma Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Payable	Get a 7-Day Free Trial															177.04	156.32	154.70	141.65	162.98

Competitive Comparison of iX Biopharma's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, iX Biopharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iX Biopharma's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iX Biopharma's Days Payable distribution charts can be found below:

* The bar in red indicates where iX Biopharma's Days Payable falls into.

Save Embed

;

Save Embed

;

iX Biopharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

iX Biopharma's Days Payable for the fiscal year that ended in Jun. 2024 is calculated as

	Days Payable (A: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2023 )	+	Accounts Payable (A: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2024 )	*	Days in Period
=	( (0.395	+	1.26)	/	2 )	/	4.911	*	365
=	0.8275					/	4.911	*	365
=	61.50

iX Biopharma's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (1.26	+	3.891)	/	2 )	/	2.884	*	365 / 2
=	2.5755					/	2.884	*	365 / 2
=	162.98

iX Biopharma Days Payable Related Terms

Thank you for viewing the detailed overview of iX Biopharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

iX Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iX Biopharma Ltd (SGX:42C) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Kim Seng Promenade, No. 14-01, Great World City East Lobby, Singapore, SGP, 237994

Website

https://www.ixbiopharma.com

iX Biopharma Ltd is a Singapore-based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. Its business segments are Specialty Pharmaceutical and Nutraceutical business segments. The firm's business segments operate in United States of America, Singapore, Australia, and China, of which the majority of the revenue comes from the United States of America. The company generates the majority of its revenue from the sale of specialty pharmaceutical products.

iX Biopharma Headlines

No Headlines